Literature DB >> 21364322

Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation.

Ida L M Candiloro1, Thomas Mikeska, Alexander Dobrovic.   

Abstract

Heterogeneous DNA methylation leads to difficulties in accurate detection and quantification of methylation. Methylation-sensitive high resolution melting (MS-HRM) is unique among regularly used methods for DNA methylation analysis in that heterogeneous methylation can be readily identified, although not quantified, by inspection of the melting curves. Bisulfite pyrosequencing has been used to estimate the level of heterogeneous methylation by quantifying methylation levels present at individual CpG dinucleotides. Sequentially combining the two methodologies using MS-HRM to screen the amplification products prior to bisulfite pyrosequencing would be advantageous. This would not only replace the quality control step using agarose gel analysis prior to the pyrosequencing step but would also provide important qualitative information in its own right. We chose to analyze DAPK1 as it is an important tumor suppressor gene frequently heterogeneously methylated in a number of malignancies, including chronic lymphocytic leukemia (CLL). A region of the DAPK1 promoter was analyzed in ten CLL samples by MS-HRM. By using a biotinylated primer, bisulfite pyrosequencing could be used to directly analyze the samples. MS-HRM revealed the presence of various extents of heterogeneous DAPK1 methylation in all CLL samples. Further analysis of the biotinylated MS-HRM products by bisulfite pyrosequencing provided quantitative information for each CpG dinucleotide analyzed, and confirmed the presence of heterogeneous DNA methylation. Whereas each method could be used individually, MS-HRM and bisulfite pyrosequencing provided complementary information for the assessment of heterogeneous methylation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21364322      PMCID: PMC3100767          DOI: 10.4161/epi.6.4.14853

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  35 in total

1.  DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology?

Authors:  A Aggerholm; P Hokland
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

2.  Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis.

Authors:  Karen Uhlmann; Anja Brinckmann; Mohammad R Toliat; Heide Ritter; Peter Nürnberg
Journal:  Electrophoresis       Date:  2002-12       Impact factor: 3.535

3.  Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing.

Authors:  Jörg Tost; Jenny Dunker; Ivo Glynne Gut
Journal:  Biotechniques       Date:  2003-07       Impact factor: 1.993

4.  Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.

Authors:  S L Rosas; W Koch; M G da Costa Carvalho; L Wu; J Califano; W Westra; J Jen; D Sidransky
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

5.  Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis.

Authors:  Thomas Mikeska; Christoph Bock; Osman El-Maarri; Anika Hübner; Denise Ehrentraut; Johannes Schramm; Jörg Felsberg; Philip Kahl; Reinhard Büttner; Torsten Pietsch; Andreas Waha
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

Review 6.  Biomarkers for early detection of breast cancer: what, when, and where?

Authors:  Victor V Levenson
Journal:  Biochim Biophys Acta       Date:  2007-02-12

7.  Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.

Authors:  Beatrix Versmold; Jörg Felsberg; Thomas Mikeska; Denise Ehrentraut; Juliane Köhler; Juergen A Hampl; Gabriele Röhn; Dieter Niederacher; Beate Betz; Martin Hellmich; Torsten Pietsch; Rita K Schmutzler; Andreas Waha
Journal:  Int J Cancer       Date:  2007-08-01       Impact factor: 7.396

8.  DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers.

Authors:  A Satoh; M Toyota; F Itoh; T Kikuchi; T Obata; Y Sasaki; H Suzuki; A Yawata; M Kusano; M Fujita; M Hosokawa; K Yanagihara; T Tokino; K Imai
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

9.  Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection.

Authors:  Lasse S Kristensen; Thomas Mikeska; Michael Krypuy; Alexander Dobrovic
Journal:  Nucleic Acids Res       Date:  2008-03-15       Impact factor: 16.971

10.  Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene.

Authors:  Ida L M Candiloro; Thomas Mikeska; Peter Hokland; Alexander Dobrovic
Journal:  Epigenetics Chromatin       Date:  2008-11-03       Impact factor: 4.954

View more
  27 in total

1.  ID4 is frequently downregulated and partially hypermethylated in prostate cancer.

Authors:  Anna Vinarskaja; Wolfgang Goering; Marc Ingenwerth; Wolfgang A Schulz
Journal:  World J Urol       Date:  2011-09-01       Impact factor: 4.226

2.  Epigenetic mechanisms of protein tyrosine phosphatase 6 suppression in diffuse large B-cell lymphoma: implications for epigenetic therapy.

Authors:  T E Witzig; G Hu; S M Offer; L E Wellik; J J Han; M J Stenson; A Dogan; R B Diasio; M Gupta
Journal:  Leukemia       Date:  2013-08-27       Impact factor: 11.528

3.  Fat mass and obesity-associated (FTO) gene epigenetic modifications in gestational diabetes: new insights and possible pathophysiological connections.

Authors:  Marica Franzago; Federica Fraticelli; Michele Marchioni; Marta Di Nicola; Francesca Di Sebastiano; Marco Liberati; Liborio Stuppia; Ester Vitacolonna
Journal:  Acta Diabetol       Date:  2021-03-20       Impact factor: 4.280

4.  The limitations of locus specific methylation qualification and quantification in clinical material.

Authors:  Tomasz K Wojdacz
Journal:  Front Genet       Date:  2012-02-28       Impact factor: 4.599

5.  Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features.

Authors:  Jia-Min B Pang; Siddhartha Deb; Elena A Takano; David J Byrne; Nicholas Jene; Alice Boulghourjian; Anne Holliday; Ewan Millar; C Soon Lee; Sandra A O'Toole; Alexander Dobrovic; Stephen B Fox
Journal:  Breast Cancer Res       Date:  2014-10-21       Impact factor: 6.466

6.  Effects of phthalate exposure on asthma may be mediated through alterations in DNA methylation.

Authors:  I-Jen Wang; Wilfried Jj Karmaus; Su-Lien Chen; John W Holloway; Susan Ewart
Journal:  Clin Epigenetics       Date:  2015-03-15       Impact factor: 6.551

7.  Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.

Authors:  Melanie Spitzwieser; Elisabeth Holzweber; Georg Pfeiler; Stefan Hacker; Margit Cichna-Markl
Journal:  Breast Cancer Res       Date:  2015-09-14       Impact factor: 6.466

8.  Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation.

Authors:  Francesca Migheli; Andrea Stoccoro; Fabio Coppedè; Wan Adnan Wan Omar; Alessandra Failli; Rita Consolini; Massimo Seccia; Roberto Spisni; Paolo Miccoli; John C Mathers; Lucia Migliore
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

9.  E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.

Authors:  Liming Li; Cui Xu; Jia Long; Danbei Shen; Wuqing Zhou; Qiyan Zhou; Jia Yang; Mingjun Jiang
Journal:  Oncotarget       Date:  2015-09-15

10.  Identification and characterization of locus-specific methylation patterns within novel loci undergoing hypermethylation during breast cancer pathogenesis.

Authors:  Tomasz K Wojdacz; Johanne A Windeløv; Britta B Thestrup; Tine E Damsgaard; Jens Overgaard; Lise Hansen
Journal:  Breast Cancer Res       Date:  2014-02-03       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.